Skip to main content
Top
Published in: Current Infectious Disease Reports 5/2011

01-10-2011

Early and Adequate Antibiotic Therapy in the Treatment of Severe Sepsis and Septic Shock

Authors: John D. Dickinson, Marin H. Kollef

Published in: Current Infectious Disease Reports | Issue 5/2011

Login to get access

Abstract

Severe sepsis and septic shock are conditions that pose difficult challenges to physicians and the health care system. In the past 10 years, a number of retrospective and prospective observational studies have shed light on the importance of a rapid and systematic approach to treatment of these conditions. A key component is early and appropriate use of antibiotics. Delay of even 6 h can dramatically increase hospital mortality. In addition, multivariate analyses have demonstrated that inappropriate initial antibiotics lead to worse outcomes. The treating physician can rapidly identify risk factors for initial inappropriate antibiotics at the bedside, such as recent antibiotic therapy or recent hospitalization. Organized antibiotic order sets have been shown to significantly improve timely appropriate antibiotic administration in septic patients. Finally, emerging laboratory data suggest that early in the course of septic shock, the pharmacokinetics of common broad spectrum antibiotics may be significantly altered due to increased volumes of distribution having dosing implications for antibiotics in septic shock.
Literature
1.
go back to reference • Dellinger RP, Zimmerman JL, Vincent JL, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296–327. A thorough summary of important guidelines in the diagnosis and management of septic shock. PubMedCrossRef • Dellinger RP, Zimmerman JL, Vincent JL, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296–327. A thorough summary of important guidelines in the diagnosis and management of septic shock. PubMedCrossRef
2.
go back to reference Vincent JL, Korkut HA. Defining sepsis. Clin in Chest Med. 2008;29:585–90.CrossRef Vincent JL, Korkut HA. Defining sepsis. Clin in Chest Med. 2008;29:585–90.CrossRef
3.
go back to reference Alberti C, Brun-Buisson H, Le Gall R, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med. 2002;28:108–21.PubMedCrossRef Alberti C, Brun-Buisson H, Le Gall R, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med. 2002;28:108–21.PubMedCrossRef
4.
go back to reference Vincent JL, Sakr Y, Payen D, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34:344–53.PubMedCrossRef Vincent JL, Sakr Y, Payen D, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34:344–53.PubMedCrossRef
5.
go back to reference Martin GS, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. NEJM. 2003;348:1546–54.PubMedCrossRef Martin GS, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. NEJM. 2003;348:1546–54.PubMedCrossRef
6.
go back to reference Drombrovskiy VY, Sunderram J, Martin AA, Paz HL. Rapid Increase in hospitalization and mortality rates for severe sepsis in the United States. Crit Care Med. 2007;35:1244–50.CrossRef Drombrovskiy VY, Sunderram J, Martin AA, Paz HL. Rapid Increase in hospitalization and mortality rates for severe sepsis in the United States. Crit Care Med. 2007;35:1244–50.CrossRef
8.
go back to reference Burchardi H, Schneider H. Economic aspects of severe sepsis: a review of intensive care unit cost of illness and cost effectiveness of therapy. Pharmacoeconomics. 2004;22:793–813.PubMedCrossRef Burchardi H, Schneider H. Economic aspects of severe sepsis: a review of intensive care unit cost of illness and cost effectiveness of therapy. Pharmacoeconomics. 2004;22:793–813.PubMedCrossRef
9.
go back to reference Shorr AF, Micek S, Jackson WL, Kollef MH. Economic implications of an evidence-based sepsis protocol: can we improve outcomes and lower costs? Crit Care Med. 2007;35:1257–62.PubMedCrossRef Shorr AF, Micek S, Jackson WL, Kollef MH. Economic implications of an evidence-based sepsis protocol: can we improve outcomes and lower costs? Crit Care Med. 2007;35:1257–62.PubMedCrossRef
10.
go back to reference Oterro RM, Nuygen HB, Rivers E, et al. Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest. 2006;130:1579–95.CrossRef Oterro RM, Nuygen HB, Rivers E, et al. Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest. 2006;130:1579–95.CrossRef
11.
go back to reference Talan DA, Zibulewky J. Relationship of clinical presentation to time to antibiotics for the emergency department management of suspected bacterial meningitis. Ann Emerg Med. 1993;22:1733–8.PubMedCrossRef Talan DA, Zibulewky J. Relationship of clinical presentation to time to antibiotics for the emergency department management of suspected bacterial meningitis. Ann Emerg Med. 1993;22:1733–8.PubMedCrossRef
12.
go back to reference Lebel MH. Adverse outcome of bacterial meningitis due to delayed sterilization of cerebrospinal fluid. Antibiot Chemother. 1992;45:226–38.PubMed Lebel MH. Adverse outcome of bacterial meningitis due to delayed sterilization of cerebrospinal fluid. Antibiot Chemother. 1992;45:226–38.PubMed
13.
go back to reference Miner J, Heegaard W, Mapes A, Biros M. Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center. J Emerg Med. 2001;21:387–92.PubMedCrossRef Miner J, Heegaard W, Mapes A, Biros M. Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center. J Emerg Med. 2001;21:387–92.PubMedCrossRef
14.
go back to reference Larché J, Azoulay E, Schlemmer B, et al. Improved survival of critically ill cancer patients with septic shock. Intensive Care Med. 2003;29:1688–95.PubMedCrossRef Larché J, Azoulay E, Schlemmer B, et al. Improved survival of critically ill cancer patients with septic shock. Intensive Care Med. 2003;29:1688–95.PubMedCrossRef
15.
go back to reference Kumar A, Roberts D, Cheang M, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–96.PubMedCrossRef Kumar A, Roberts D, Cheang M, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–96.PubMedCrossRef
16.
go back to reference •• Kumar A, Ellis P, Chateau D, et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 2009;136:1237–48. Authors demonstrated that timely infusion and appropriate antibiotics had a profound effect on hospital mortality from severe sepsis and septic shock independent of other co morbid conditions. PubMedCrossRef •• Kumar A, Ellis P, Chateau D, et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 2009;136:1237–48. Authors demonstrated that timely infusion and appropriate antibiotics had a profound effect on hospital mortality from severe sepsis and septic shock independent of other co morbid conditions. PubMedCrossRef
17.
go back to reference • Ferrer R, Artigas A, Sirvent JM, et al. Effectiveness of treatments for severe sepsis. Am J Resp Crit Care Med 2009;180:861–66. In a ICU patient cohort after the implementation of the Surviving Sepsis Guidelines, administration of timely appropriate antibiotics and drotrecogin-α were associated with reduced mortality from septic shock. PubMedCrossRef • Ferrer R, Artigas A, Sirvent JM, et al. Effectiveness of treatments for severe sepsis. Am J Resp Crit Care Med 2009;180:861–66. In a ICU patient cohort after the implementation of the Surviving Sepsis Guidelines, administration of timely appropriate antibiotics and drotrecogin-α were associated with reduced mortality from septic shock. PubMedCrossRef
18.
go back to reference Kollef MH, Morrow LE, Baughman RP, et al. Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes–proceedings of the HCAP Summit. Clin Infect Dis. 2008;46:S296–334.PubMedCrossRef Kollef MH, Morrow LE, Baughman RP, et al. Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes–proceedings of the HCAP Summit. Clin Infect Dis. 2008;46:S296–334.PubMedCrossRef
19.
go back to reference Kollef MH, Sherman G, Ward S, Fraser V. Inadequate antimicrobial treatment of infections. Chest. 1999;115:462–74.PubMedCrossRef Kollef MH, Sherman G, Ward S, Fraser V. Inadequate antimicrobial treatment of infections. Chest. 1999;115:462–74.PubMedCrossRef
20.
go back to reference Ibrahim EH, Sherman G, Ward S, et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000;118:146–55.PubMedCrossRef Ibrahim EH, Sherman G, Ward S, et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000;118:146–55.PubMedCrossRef
21.
go back to reference Garnacho-Montero J, Garcia-Garmendia JL, Oritz-Leyba C, et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med. 2003;31:2742–51.PubMedCrossRef Garnacho-Montero J, Garcia-Garmendia JL, Oritz-Leyba C, et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med. 2003;31:2742–51.PubMedCrossRef
22.
go back to reference Friedman ND, Kayes KS, Sexton DJ, et al. Healthcare-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137:791–7.PubMed Friedman ND, Kayes KS, Sexton DJ, et al. Healthcare-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137:791–7.PubMed
23.
go back to reference Niederman MS, Craven DE. ATS Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Resp Crit Care Med. 2005;171:388–416.CrossRef Niederman MS, Craven DE. ATS Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Resp Crit Care Med. 2005;171:388–416.CrossRef
24.
go back to reference •• Micek S, Welch E, Kollef MH, et al. Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: A retrospective analysis. Antimicrob Agents Chemother 2010;54:1742–48. A single center study of serious Gram negative blood stream infections demonstrated initial combination antibiotics decreased the risk of receiving inappropriate antibiotics. A higher mortality and increased hospital length of stay for those receiving inappropriate antibiotics. PubMedCrossRef •• Micek S, Welch E, Kollef MH, et al. Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: A retrospective analysis. Antimicrob Agents Chemother 2010;54:1742–48. A single center study of serious Gram negative blood stream infections demonstrated initial combination antibiotics decreased the risk of receiving inappropriate antibiotics. A higher mortality and increased hospital length of stay for those receiving inappropriate antibiotics. PubMedCrossRef
25.
go back to reference Heyland D, Dodek P, Cook K, et al. Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia. Crit Car Med. 2008;36:737–44.CrossRef Heyland D, Dodek P, Cook K, et al. Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia. Crit Car Med. 2008;36:737–44.CrossRef
26.
go back to reference Beardsley J, Williamson JC, Bowton DL, et al. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. Chest. 2006;130:787–93.PubMedCrossRef Beardsley J, Williamson JC, Bowton DL, et al. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. Chest. 2006;130:787–93.PubMedCrossRef
27.
go back to reference Dejace P, Klastersky J. Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside. Am J Med. 1986;80:29–38.PubMedCrossRef Dejace P, Klastersky J. Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside. Am J Med. 1986;80:29–38.PubMedCrossRef
28.
go back to reference Bodey GP. Evolution of antibiotic therapy for infection in neutropenic patients: studies at M.D. Anderson Hospital. Review Infect Dis. 1989;11:S1582–90.CrossRef Bodey GP. Evolution of antibiotic therapy for infection in neutropenic patients: studies at M.D. Anderson Hospital. Review Infect Dis. 1989;11:S1582–90.CrossRef
29.
go back to reference •• Kumar A, Zarychanski R, Doucette S, et al. Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. Chest 2010;38:1773–85. This study demonstrated that initial combination antibiotics for septic shock increased 28-day survival (P = 0.0002) along with pressor free and ventilator free days in the ICU. •• Kumar A, Zarychanski R, Doucette S, et al. Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. Chest 2010;38:1773–85. This study demonstrated that initial combination antibiotics for septic shock increased 28-day survival (P = 0.0002) along with pressor free and ventilator free days in the ICU.
30.
go back to reference • Mical P, Simona G, Leibovici L, et al. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis. Cochrane Database Sys Rev 2006;25:CD003344. A large meta-analysis of over 7000 patients with sepsis, pneumonia, endocarditis, and other clinical conditions revealed no benefit to initial combination antibiotics compared to monotherapy. • Mical P, Simona G, Leibovici L, et al. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis. Cochrane Database Sys Rev 2006;25:CD003344. A large meta-analysis of over 7000 patients with sepsis, pneumonia, endocarditis, and other clinical conditions revealed no benefit to initial combination antibiotics compared to monotherapy.
31.
go back to reference Hamm C, Goldmann B, Meinertz T, et al. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. NEJM. 1997;337(23):1648–53.PubMedCrossRef Hamm C, Goldmann B, Meinertz T, et al. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. NEJM. 1997;337(23):1648–53.PubMedCrossRef
32.
go back to reference Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/AHA Guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation. 1999;100:1016–30.PubMed Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/AHA Guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation. 1999;100:1016–30.PubMed
33.
go back to reference Rivers E, Nguyen B, Peterson E, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. NEJM. 2001;345:1368–77.PubMedCrossRef Rivers E, Nguyen B, Peterson E, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. NEJM. 2001;345:1368–77.PubMedCrossRef
34.
go back to reference Micek S, Roubinian N, Heuring T, et al. Before-after study of a standardized hospital order set for the management of septic shock. Crit Car Med. 2006;34:2707–13.CrossRef Micek S, Roubinian N, Heuring T, et al. Before-after study of a standardized hospital order set for the management of septic shock. Crit Car Med. 2006;34:2707–13.CrossRef
35.
go back to reference •• Levy MM, Dellinger RP, Regen S, et al. The surviving Sepsis Campaign: results of an international guideline based performance improvement program targeting severe sepsis. Intensive Care Med 2010;36:222–31. This large study of patients with severe sepsis compared outcomes after the initiating The Surviving Sepsis Guidelines. PubMedCrossRef •• Levy MM, Dellinger RP, Regen S, et al. The surviving Sepsis Campaign: results of an international guideline based performance improvement program targeting severe sepsis. Intensive Care Med 2010;36:222–31. This large study of patients with severe sepsis compared outcomes after the initiating The Surviving Sepsis Guidelines. PubMedCrossRef
36.
go back to reference • Barochia AV, Cui X, Vitberg D, et al. Bundled care for septic shock: an analysis of clinical trials. Crit Care Med 2010;38:668–78. The authors compared multiple studies of the impact of bundled order sets for septic shock. Post-intervention groups had consistent increase in survival and timely, appropriate antibiotic use. PubMedCrossRef • Barochia AV, Cui X, Vitberg D, et al. Bundled care for septic shock: an analysis of clinical trials. Crit Care Med 2010;38:668–78. The authors compared multiple studies of the impact of bundled order sets for septic shock. Post-intervention groups had consistent increase in survival and timely, appropriate antibiotic use. PubMedCrossRef
37.
go back to reference Sharma S, Kumar A. Antimicrobial management of sepsis and septic shock. Clin Chest Med. 2008;29:677–87.PubMedCrossRef Sharma S, Kumar A. Antimicrobial management of sepsis and septic shock. Clin Chest Med. 2008;29:677–87.PubMedCrossRef
38.
go back to reference • Pea F, Viele P. Bench-to-bedside review: appropriate antibiotic therapy in severe sepsis and septic shock—does the dose matter? Crit Care 2009;13:214. An excellent review of the pharmacokinetic and pharmacodynamic changes of antibiotic therapy for severe sepsis and septic shock. PubMedCrossRef • Pea F, Viele P. Bench-to-bedside review: appropriate antibiotic therapy in severe sepsis and septic shock—does the dose matter? Crit Care 2009;13:214. An excellent review of the pharmacokinetic and pharmacodynamic changes of antibiotic therapy for severe sepsis and septic shock. PubMedCrossRef
39.
go back to reference Rea RS, Capitano B, Smith R, et al. Suboptimal aminoglycoside dosing in critically ill patients. Ther Drug Monit. 2008;30:674–81.PubMedCrossRef Rea RS, Capitano B, Smith R, et al. Suboptimal aminoglycoside dosing in critically ill patients. Ther Drug Monit. 2008;30:674–81.PubMedCrossRef
40.
go back to reference Joukhadar C, Frossard M, Mayer BX, et al. Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock. Crit Care Med. 2001;29:385–91.PubMedCrossRef Joukhadar C, Frossard M, Mayer BX, et al. Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock. Crit Care Med. 2001;29:385–91.PubMedCrossRef
41.
go back to reference del Mar Fernandez de Gatta Garcia M, Revilla N, Calvo MV, et al. Pharmacokinetic/ pharmacodynamic analysis of vancomycin in ICU patients. Intensive Care Med 2007;33:279–85. del Mar Fernandez de Gatta Garcia M, Revilla N, Calvo MV, et al. Pharmacokinetic/ pharmacodynamic analysis of vancomycin in ICU patients. Intensive Care Med 2007;33:279–85.
42.
go back to reference Varghese JM, Roberts JA, Lipman J. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock. Crit Care Clin. 2011;27:19–34.PubMedCrossRef Varghese JM, Roberts JA, Lipman J. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock. Crit Care Clin. 2011;27:19–34.PubMedCrossRef
43.
go back to reference Tam VH, McKinnon PS, Akins RL, et al. Pharmacodynamics of cefepime in patients with Gram-negative infections. J AntimicrobChemother. 2002;50:425–8.CrossRef Tam VH, McKinnon PS, Akins RL, et al. Pharmacodynamics of cefepime in patients with Gram-negative infections. J AntimicrobChemother. 2002;50:425–8.CrossRef
44.
go back to reference McKinnon PS, Paladino JA, Schentag JJ. Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T > MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections. Int J Antimicrob Agents. 2008;31:345–51.PubMedCrossRef McKinnon PS, Paladino JA, Schentag JJ. Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T > MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections. Int J Antimicrob Agents. 2008;31:345–51.PubMedCrossRef
45.
go back to reference •• Taccone FS, Laterre PF, Vincent JL, et al. Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock. Crit Care Med 2010;14:R126. A prospective study of the pharmacokinetics of 4 common b-lactams administered as first dose antibiotics for septic shock revealed only meropenem reached the target serum MIC for pseudomonas infections. •• Taccone FS, Laterre PF, Vincent JL, et al. Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock. Crit Care Med 2010;14:R126. A prospective study of the pharmacokinetics of 4 common b-lactams administered as first dose antibiotics for septic shock revealed only meropenem reached the target serum MIC for pseudomonas infections.
46.
go back to reference Roberts JA, Webb S, Paterson D, et al. A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics. Crit Care Med. 2009;37:2071–8.PubMedCrossRef Roberts JA, Webb S, Paterson D, et al. A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics. Crit Care Med. 2009;37:2071–8.PubMedCrossRef
47.
go back to reference Harbarth S, Garbino J, Lew D, et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med. 2003;115:529–35.PubMedCrossRef Harbarth S, Garbino J, Lew D, et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med. 2003;115:529–35.PubMedCrossRef
48.
go back to reference Zaragoza R, Artero A, Camarena J, et al. The influence of inadequate empirical antimicrobial treatment on patient with blood stream infections in an intensive care unit. Clin Microbiol Infect. 2003;9:412–8.PubMedCrossRef Zaragoza R, Artero A, Camarena J, et al. The influence of inadequate empirical antimicrobial treatment on patient with blood stream infections in an intensive care unit. Clin Microbiol Infect. 2003;9:412–8.PubMedCrossRef
49.
go back to reference Leone M, Bourgoin A, Martin C, et al. Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome. Crit Care Med. 2003;31:462–7.PubMedCrossRef Leone M, Bourgoin A, Martin C, et al. Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome. Crit Care Med. 2003;31:462–7.PubMedCrossRef
50.
go back to reference Shorr AF, Micek S, Reichley RM, Kollef MH. Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay. Crit Care Med. 2011;39:46–51.PubMedCrossRef Shorr AF, Micek S, Reichley RM, Kollef MH. Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay. Crit Care Med. 2011;39:46–51.PubMedCrossRef
Metadata
Title
Early and Adequate Antibiotic Therapy in the Treatment of Severe Sepsis and Septic Shock
Authors
John D. Dickinson
Marin H. Kollef
Publication date
01-10-2011
Publisher
Current Science Inc.
Published in
Current Infectious Disease Reports / Issue 5/2011
Print ISSN: 1523-3847
Electronic ISSN: 1534-3146
DOI
https://doi.org/10.1007/s11908-011-0206-8

Other articles of this Issue 5/2011

Current Infectious Disease Reports 5/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.